Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-119873
Filing Date
2026-03-23
Accepted
2026-03-23 16:44:40
Documents
102
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K stro-20251231.htm   iXBRL 10-K 4571858
2 EX-3.1 stro-ex3_1.htm EX-3.1 57050
3 EX-23.1 stro-ex23_1.htm EX-23.1 16340
4 EX-31.1 stro-ex31_1.htm EX-31.1 17061
5 EX-31.2 stro-ex31_2.htm EX-31.2 17455
6 EX-32.1 stro-ex32_1.htm EX-32.1 9013
7 EX-32.2 stro-ex32_2.htm EX-32.2 9052
8 GRAPHIC img122116034_0.jpg GRAPHIC 30349
9 GRAPHIC img122116034_1.jpg GRAPHIC 18812
10 GRAPHIC img122116034_2.jpg GRAPHIC 21726
11 GRAPHIC img122116034_3.jpg GRAPHIC 735013
  Complete submission text file 0001193125-26-119873.txt   18333819

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT stro-20251231.xsd EX-101.SCH 2038298
106 EXTRACTED XBRL INSTANCE DOCUMENT stro-20251231_htm.xml XML 3120480
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38662 | Film No.: 26782976
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)